Introduction/Objective. Higher rates of morbidity and mortality from the
infection of COVID-19 have been recorded among people with mental disorders,
especially among those suffering from severe forms, so they should be
prioritized during vaccination campaigns. The aim of this study was to
examine possible predictors of acceptance of vaccination against COVID-19 in
patients with mental disorders. Methods. This retrospective study was
conducted from January 2021 until January 2022 and included 458 patients
with mental disorders treated at the Dr Laza Lazarevic Clinic for Mental
Disorders in Belgrade, Serbia. Patients were segregated into the vaccinated
and unvaccinated group depending on their vaccination status. Questionnaire
developed specifically for the present study was administered to gather the
participants? sociodemographic characteristics, while data related to their
mental disorders, COVID-19 infection, and comorbidities was obtained from
their medical records. Results. Eighty percent of the vaccinated group
opted for the Sinopharm vaccine. Significantly higher percentage of
vaccinated patients was hospitalized during the study period and had
comorbidities compared to the unvaccinated group (51.4% vs. 32.6% and 52.8%
vs. 37.5%, respectively). Education level, employment status, marital
status, diagnostic category, and comorbidities were statistically
significant predictors of COVID-19 vaccination uptake among people with
mental disorders. Conclusion. Our findings show that higher level of
education, greater trust in the healthcare system, and knowledge of the
available vaccination points significantly contribute to the vaccination
uptake in this vulnerable population group.